Personensuche
Personensuche
Es wurde 1 Person gefunden.
Institut für Virologie der Medizinischen Fakultät
Anschrift
Hufelandstr. 55 (Postanschrift)
45122 Essen
45122 Essen
Telefon
E-Mail
Webseite
Funktionen
-
Wiss. Mitarbeiter/in und Wiss. Assistent/in, Institut für Virologie
Aktuelle Veranstaltungen
-
2023 SS
- Seminar für Doktoranden - Infektiologie
- Persistierende Virusinfektionen (*)
- Doktorandenkolloquium (*)
- Sommerakademie 2022 - Infektionsimmunologie
- Anleitung zum wissenschaftlichen Arbeiten (*)
- Hygiene, Mikrobiologie, Virologie (WA)
- Wiss. Arbeiten Klinik für Infektiologie
- Hygiene, Mikrobiologie, Virologie (PV)
- Differentialdiagnose Innere Krankheiten
Vergangene Veranstaltungen (max. 10)
-
2022 WS
-
2022 SS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations : A retrospective studyIn: Frontiers in Immunology Jg. 14 (2023) S. 1143870ISSN: 1664-3224Online Volltext: dx.doi.org/ (Open Access)
-
Patients with SARS-CoV-2-Induced Viral Sepsis Simultaneously Show Immune Activation, Impaired Immune Function and a Procoagulatory Disease StateIn: Vaccines Jg. 11 (2023) Nr. 2,ISSN: 2076-393XOnline Volltext: dx.doi.org/ (Open Access)
-
Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patientsIn: Human Immunology (2023) in pressISSN: 0198-8859; 1879-1166Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
COVID-19 in Elderly, Immunocompromised or Diabetic Patients : From Immune Monitoring to Clinical Management in the HospitalIn: Viruses Jg. 14 (2022) Nr. 4,ISSN: 1999-4915Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant RecipientsIn: Vaccines Jg. 10 (2022) Nr. 6,ISSN: 2076-393XOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Cellular and Humoral Immunity against Different SARS-CoV-2 Variants Is Detectable but Reduced in Vaccinated Kidney Transplant PatientsIn: Vaccines Jg. 10 (2022) Nr. 8,ISSN: 2076-393XOnline Volltext: dx.doi.org/ (Open Access)
-
Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on HemodialysisIn: Vaccines Jg. 10 (2022) Nr. 2,ISSN: 2076-393XOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infectionIn: Proceedings of the National Academy of Sciences of the United States of America (PNAS) Jg. 119 (2022) Nr. 8,ISSN: 1091-6490; 0027-8424Online Volltext: dx.doi.org/ (Open Access)
-
Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk PatientsIn: Viruses Jg. 15 (2022) Nr. 1,ISSN: 1999-4915Online Volltext: dx.doi.org/ (Open Access)
-
Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatmentIn: Frontiers in Immunology Jg. 13 (2022)ISSN: 1664-3224Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Prospective, Longitudinal Study on Specific Cellular Immune Responses after Vaccination with an Adjuvanted, Recombinant Zoster Vaccine in Kidney Transplant RecipientsIn: Vaccines Jg. 10 (2022) Nr. 6,ISSN: 2076-393XOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Silencing of proinflammatory NF-κB and inhibition of herpes simplex virus (HSV) replication by ultrasmall gold nanoparticles (2 nm) conjugated with small-interfering RNAIn: Nanoscale Advances Jg. 4 (2022) S. 4502 - 4516ISSN: 2516-0230Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Superior antiviral activity of IFNβ in genital HSV-1 infectionIn: Frontiers in Cellular and Infection Microbiology Jg. 12 (2022)ISSN: 2235-2988Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccinationIn: Frontiers in Immunology Jg. 13 (2022)ISSN: 1664-3224Online Volltext: dx.doi.org/ (Open Access)
-
Upregulation of miRNA-200c during Disease Progression in COVID-19 PatientsIn: Journal of Clinical Medicine (JCM) Jg. 12 (2022) Nr. 1,ISSN: 2077-0383Online Volltext: dx.doi.org/ (Open Access)
-
A realistic transfer method reveals low risk of SARS-CoV-2 transmission via contaminated euro coins and banknotesIn: iScience Jg. 24 (2021) Nr. 8,ISSN: 2589-0042Online Volltext: dx.doi.org/ (Open Access)
-
Antiviral Active Compounds Derived from Natural Sources against Herpes Simplex VirusesIn: Viruses Jg. 13 (2021) Nr. 7,ISSN: 1999-4915Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Benefit of transaminase elevations in establishing functional cure of HBV infection during nap-based combination therapyIn: Journal of Viral Hepatitis Jg. 28 (2021) Nr. 5, S. 817 - 825ISSN: 1365-2893; 1352-0504Online Volltext: dx.doi.org/
-
Cellular immunity in COVID-19 convalescents with PCR-confirmed infection but with undetectable SARS-CoV-2-Specific IgGIn: Emerging Infectious Diseases (EID) Jg. 27 (2021) Nr. 1, S. 122 - 129ISSN: 1080-6059; 1080-6040Online Volltext: dx.doi.org/ (Open Access)
-
Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476In: The Journal of Hospital Infection Jg. 111 (2021) S. 180 - 183ISSN: 1532-2939; 0195-6701Online Volltext: dx.doi.org/ (Open Access)
-
Convalescent plasma treatment of critically ill intensive care COVID-19 patientsIn: Transfusion Jg. 61 (2021) Nr. 5, S. 1394 - 1403ISSN: 1537-2995; 0041-1132Online Volltext: dx.doi.org/ (Open Access)
-
Disinfection of SARS-CoV-2 Contaminated Surfaces of Personal Items with UVC-LED Disinfection BoxesIn: Viruses Jg. 13 (2021) Nr. 4,ISSN: 1999-4915Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Erratum to: Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2In: The Journal of Infectious Diseases (JID) Jg. 223 (2021) Nr. 3, S. 541 - 541ISSN: 0022-1899; 1537-6613Online Volltext: dx.doi.org/ (Open Access)
-
Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main ProteaseIn: Viruses Jg. 13 (2021) Nr. 4,ISSN: 1999-4915Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Long-term sars-cov-2 specific immunity is affected by the severity of initial covid-19 and patient ageIn: Journal of Clinical Medicine (JCM) Jg. 10 (2021) Nr. 19,ISSN: 2077-0383Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Pasteurization Inactivates SARS-CoV-2-Spiked Breast MilkIn: Pediatrics / American Academy of Pediatrics (AAP) (Hrsg.) Jg. 147 (2021) Nr. 1, S. e2020031690ISSN: 1098-4275; 0031-4005Online Volltext: dx.doi.org/
-
Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139‐Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus CoinfectionIn: Hepatology Communications Jg. 5 (2021) Nr. 2, S. 189 - 202ISSN: 2471-254XOnline Volltext: dx.doi.org/ (Open Access)
-
Recent Antiviral Treatment and Vaccination Strategies against SARS-CoV-2In: Klinische Monatsblätter für Augenheilkunde Jg. 238 (2021) Nr. 5, S. 569 - 578ISSN: 0344-6387; 0023-2165; 1439-3999; 0344-6360Online Volltext: dx.doi.org/
-
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19In: Nature Communications Jg. 12 (2021) Nr. 1, S. 1813ISSN: 2041-1723Online Volltext: dx.doi.org/ (Open Access)
-
SARS-CoV-2-specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasmaIn: Journal of Medical Virology Jg. 93 (2021) Nr. 5, S. 3047 - 3054ISSN: 0146-6615; 1096-9071Online Volltext: dx.doi.org/ (Open Access)
-
Sars-cov-2 seroprevalence in healthcare workers in Germany : A follow-up studyIn: International Journal of Environmental Research and Public Health = IJERPH Jg. 18 (2021) Nr. 9,ISSN: 1660-4601; 1661-7827Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Turmeric root and its bioactive ingredient curcumin effectively neutralize sars-cov-2 in vitroIn: Viruses Jg. 13 (2021) Nr. 10,ISSN: 1999-4915Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Virucidal efficacy of different formulations for hand and surface disinfection targeting SARS CoV-2In: The Journal of Hospital Infection Jg. 112 (2021) S. 27 - 30ISSN: 1532-2939; 0195-6701Online Volltext: dx.doi.org/ (Open Access)
-
A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral CompoundsIn: Frontiers in Immunology Jg. 11 (2020) S. 573526ISSN: 1664-3224Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
A Novel, Broad-Acting Peptide Inhibitor of Double-Stranded DNA Virus Gene Expression and ReplicationIn: Frontiers in Microbiology Jg. 11 (2020) S. 601555ISSN: 1664-302XOnline Volltext: dx.doi.org/ (Open Access)
-
Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe diseaseIn: Nature Communications Jg. 11 (2020) Nr. 1, S. 1338ISSN: 2041-1723Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Cell fusion induced by a fusion-active form of human cytomegalovirus glycoprotein B (gB) is inhibited by antibodies directed at antigenic domain 5 in the ectodomain of gBIn: Journal of Virology Jg. 94 (2020) Nr. 18,ISSN: 1098-5514; 0022-538XOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against Herpes Simplex Virus Type 1 reactivationsIn: bioRxiv (2020)Online Volltext: dx.doi.org/ (Open Access)
-
HSV-1 Modulates IL-6 Receptor Expression on Human Dendritic CellsIn: Frontiers in Immunology Jg. 11 (2020) S. 1970ISSN: 1664-3224Online Volltext: dx.doi.org/ (Open Access)
-
Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1In: Vaccines Jg. 8 (2020) Nr. 3, S. 478ISSN: 2076-393XOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Herpes Simplex Virus Type-2 Paralyzes the Function of Monocyte-Derived Dendritic CellsIn: Viruses Jg. 12 (2020) Nr. 1,ISSN: 1999-4915Online Volltext: dx.doi.org/ (Open Access)
-
Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAgIn: Scientific Reports Jg. 10 (2020) Nr. 1, S. 7837ISSN: 2045-2322Online Volltext: dx.doi.org/ (Open Access)
-
Moderne Infektiologie: Eindringlinge unschädlich machen: : Universitäre Infektiologie als fächerübergreifendes Konzept der stationären Patient*innenversorgungIn: Unikate: Berichte aus Forschung und Lehre (2020) Nr. 54: Medizin: Infektionskrankheiten - ein globales Problem, S. 70 - 81ISSN: 0941-746XOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Rapid quantification of SARS-CoV-2-neutralizing antibodies using propagation-defective vesicular stomatitis virus pseudotypesIn: Vaccines Jg. 8 (2020) Nr. 3, S. 386ISSN: 2076-393XOnline Volltext: dx.doi.org/ (Open Access)
-
SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patientsIn: Journal of Clinical Virology Jg. 128 (2020)ISSN: 1386-6532; 1873-5967Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide TherapyIn: Gastroenterology Jg. 158 (2020) Nr. 8, S. 2180 - 2194ISSN: 1528-0012; 0016-5085Online Volltext: dx.doi.org/ (Open Access)
-
Susceptibility of SARS-CoV-2 to UV irradiationIn: American Journal of Infection Control Jg. 48 (2020) Nr. 10, S. 1273 - 1275ISSN: 1527-3296; 0196-6553Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Virucidal Efficacy of Different Oral Rinses Against Severe Acute Respiratory Syndrome Coronavirus 2In: The Journal of Infectious Diseases (JID) Jg. 222 (2020) Nr. 8, S. 1289 - 1292ISSN: 0022-1899; 1537-6613Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Autophagic degradation of lamins facilitates the nuclear egress of herpes simplex virus type 1In: The Journal of Cell Biology (JCB) Jg. 218 (2019) Nr. 2, S. 508 - 523ISSN: 1540-8140; 0021-9525Online Volltext: dx.doi.org/ (Open Access)
-
Corrigendum to “Antibody-based immunotherapy of acyclovir resistant ocular herpes simplex virus infection” [Virology 512 (2017) 194–200]In: Virology Jg. 526 (2019) S. 231 - 232ISSN: 1096-0341; 0042-6822Online Volltext: dx.doi.org/ (Open Access)
-
Induction of herpes simplex virus type 1 cell-to-cell spread inhibiting antibodies by a calcium phosphate nanoparticle-based vaccineIn: Nanomedicine: Nanotechnology, Biology, and Medicine Jg. 16 (2019) S. 138 - 148ISSN: 1549-9642; 1549-9634Online Volltext: dx.doi.org/ (Open Access)
-
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8⁺ T Cells and Evolve at the Population LevelIn: Gastroenterology Jg. 156 (2019) Nr. 6, S. 1820 - 1833ISSN: 0016-5085; 1528-0012Online Volltext: dx.doi.org/ (Open Access)
-
Understanding HDV and HBsAg kinetics during nucleic acid polymer REP 2139 mono-therapy in HBeAg-negative chronic HBV/HDV co-infected patients via mathematical modelingIn: Journal of Hepatology Jg. 70 (2019) Nr. 1 Suppl., S. e463ISSN: 0168-8278Online Volltext: dx.doi.org/
-
A new promising candidate to overcome drug resistant herpes simplex virus infectionsIn: Antiviral Research Jg. 149 (2018) S. 202 - 210ISSN: 1872-9096; 0166-3542Online Volltext: dx.doi.org/
-
Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCRIn: Journal of Clinical Virology Jg. 99-100 (2018) S. 61 - 66ISSN: 1386-6532; 1873-5967Online Volltext: dx.doi.org/ (Open Access)
-
Detection of antibody-secreting cells specific for the cytomegalovirus and herpes simplex virus surface antigensIn: Journal of Immunological Methods Jg. 462 (2018) S. 13 - 22ISSN: 0022-1759; 1872-7905Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Establishment of High Rates of Functional Control and Reversal of Fibrosis Following Treatment of Hbeag Negative Chronic HBV Infection with REP 2139-Mg / REP 2165-Mg, Tenofovir Disoproxil Fumarate and Pegylated Interferon Alpha-2aIn: Hepatology Jg. 68 (2018) Nr. S1, S. 234A - 235AISSN: 0270-9139Online Volltext: dx.doi.org/
-
Identification of Elite Neutralizers With Broad and Potent Neutralizing Activity Against Human Cytomegalovirus (HCMV) in a Population of HCMV-Seropositive Blood DonorsIn: The Journal of Infectious Diseases Jg. 218 (2018) Nr. 6, S. 876 - 885ISSN: 0022-1899; 1537-6613Online Volltext: dx.doi.org/ (Open Access)
-
Large-scale screening of HCMV-seropositive blood donors indicates that HCMV effectively escapes from antibodies by cell-associated spreadIn: Viruses Jg. 10 (2018) Nr. 9, S. 500ISSN: 1999-4915Online Volltext: dx.doi.org/ (Open Access)
-
T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipientsIn: Journal of Clinical Virology Jg. 105 (2018) S. 91 - 96ISSN: 1386-6532; 1873-5967Online Volltext: dx.doi.org/
-
A therapeutic antiviral antibody inhibits the anterograde directed neuron-to-cell spread of herpes simplex virus and protects against ocular diseaseIn: Frontiers in Microbiology Jg. 8 (2017) S. 2115ISSN: 1664-302XOnline Volltext: dx.doi.org/ (Open Access)
-
Antibody-based immunotherapy of aciclovir resistant ocular herpes simplex virus infectionsIn: Virology Jg. 512 (2017) S. 194 - 200ISSN: 1096-0341; 0042-6822Online Volltext: dx.doi.org/ (Open Access)
-
CMV elispot assays are superior to the quantiferon CMV assay to predict protection from CMV reactivation in kidney ans liver transplant recipientsIn: HLA: Immune Response Genetics (Human Leukocyte Antigens) Jg. 89 (2017) Nr. 6, S. 375ISSN: 2059-2310; 2059-2302Online Volltext: dx.doi.org/
-
One year follow-up and HBV RNA / HBcrAg analysis in the REP 301 Trial : REP 2139 and pegylated interferon alpha-2a in Caucasian patients with chronic HBV / HDV co-infectionIn: Journal of Hepatology Jg. 66 (2017) Nr. 1, S. S96 - S97ISSN: 0168-8278; 1600-0641Online Volltext: dx.doi.org/
-
Role of L-particles during Herpes Simplex virus infectionIn: Frontiers in Microbiology Jg. 8 (2017) S. 2565ISSN: 1664-302XOnline Volltext: dx.doi.org/ (Open Access)
-
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF) : a non-randomised, open-label, phase 2 trialIn: The Lancet Gastroenterology & Hepatology Jg. 2 (2017) Nr. 12, S. 877 - 889ISSN: 2468-1253; 2468-1156Online Volltext: dx.doi.org/
-
Update on safety and efficacy in the REP 401 protocol : REP 2139-Mg or REP 2165-Mg used in combination with tenofovir disoproxil fumarate and pegylated Interferon alpha-2a in treatment naïve caucasian patients with chronic HBeAg negative HBV infectionIn: Journal of Hepatology Jg. 66 (2017) Nr. 1, S. S256 - S257ISSN: 0168-8278; 1600-0641Online Volltext: dx.doi.org/
-
Broad and potent antiviral activity of the NAE inhibitor MLN4924In: Scientific Reports Jg. 6 (2016) S. 19977ISSN: 2045-2322Online Volltext: dx.doi.org/ (Open Access)
-
Multipotent Hematopoietic Progenitors Divide Asymmetrically to Create Progenitors of the Lymphomyeloid and Erythromyeloid Lineages (vol 3, 1058, 2014)In: Stem Cell Reports Jg. 5 (2015) Nr. 1, S. 154 - 155ISSN: 2213-6711Online Volltext: dx.doi.org/ (Open Access)
-
Prevention of herpes simplex virus induced stromal keratitis by a glycoprotein B-specific monoclonal antibodyIn: PLoS ONE Jg. 10 (2015) Nr. 1, S. e0116800ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access)
-
Clinical performance of the novel DiaSorin LIAISON® XL murex : HBsAg Quant, HCV-Ab, HIV-Ab/Ag assaysIn: Journal of Clinical Virology Jg. 59 (2014) Nr. 1, S. 44 - 49ISSN: 1386-6532; 1873-5967Online Volltext: dx.doi.org/
-
Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccineIn: Vaccine Jg. 32 (2014) Nr. 39, S. 5077 - 5082ISSN: 1873-2518; 0264-410X; 1358-8745Online Volltext: dx.doi.org/
-
Multipotent hematopoietic progenitors divide asymmetrically to create progenitors of the lymphomyeloid and erythromyeloid lineagesIn: Stem Cell Reports Jg. 3 (2014) Nr. 6, S. 1058 - 1072ISSN: 2213-6711Online Volltext: dx.doi.org/ (Open Access)
-
Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibodyIn: Proceedings of the National Academy of Sciences of the United States of America (PNAS) Jg. 110 (2013) Nr. 17, S. 6760 - 6765ISSN: 1091-6490; 0027-8424Online Volltext: dx.doi.org/
-
Therapeutic vaccination of a liver transplant recipient suffering from fulminant hepatitis B during pregnancyIn: Liver Transplantation Jg. 19 (2013) Nr. 12, S. 1411 - 1412ISSN: 1527-6465; 1527-6473Online Volltext: dx.doi.org/
-
Impact of Valency of a Glycoprotein B-Specific Monoclonal Antibody on Neutralization of Herpes Simplex VirusIn: Journal of Virology Jg. 85 (2011) Nr. 4, S. 1793 - 1803ISSN: 1098-5514; 0022-538XOnline Volltext: dx.doi.org/
-
Autophagy-Mediated Breakdown of the nuclear lamina facilitates nuclear egress of HSV-1 capsids and thus generation of progeny virus in dendritic cellsIn: European Journal of Immunology Jg. 48 (2018) Nr. Suppl. 1, S. 21 - 22ISSN: 1521-4141Online Volltext: dx.doi.org/ (Open Access)
-
Updated Follow-up Analysis in the REP 401 Protocol : Treatment of HBeAg Negative Chronic HBV Infection with REP 2139 or REP 2165, Tenofovir Disoproxil Fumarate and Pegylated Interferon α-2aIn: Journal of Viral Hepatitis Jg. 25 (2018) Nr. Suppl. 2, S. 14ISSN: 1352-0504Online Volltext: dx.doi.org/
-
Updated follow-up analysis in the REP 401 protocol : Treatment HBeAg negative chronic hepatitis B infection with REP 2139 or REP 2165, tenofovir disoproxil fumarate and pegylated interferon alfa-2aIn: Journal of Hepatology Jg. 68 (2018) Nr. Suppl. 1, S. 517ISSN: 0168-8278; 1600-0641Online Volltext: dx.doi.org/
-
Update on the safety and efficacy of REP 2139 monotherapy and subsequent combination therapy with pegylated interferon Alpha-2A in caucasian patients with chronic HBV/HDV co-infectionIn: Journal of Hepatology / International Liver Congress ; EASL ; Barcelona, April 13-17, 2016 Jg. 64 (2016) Nr. 2, Suppl., S. S584 - S585ISSN: 0168-8278; 1600-0641Online Volltext: dx.doi.org/
-
Antivirale InterventionenDuisburg ; Essen (2019) 1 CD-ROM